BerGenBio ASA: BerGenBio Announces Positive Data From Phase

- The Company will discuss the topline results during its Q4 2022 results presentation on Thursday, February 16, 2023, at 10:00 AM CET - BERGEN, Norway, Feb. 15, 2023 /PRNewswire/ -- BerGenBio

Related Keywords

Norway , Oslo , United States , United Kingdom , London , City Of , Norwegian , Dennis Riedl , Graham Morrell , Jan Lilleby , Martin Olin , James Spicer , Prnewswire Bergenbio , Investor Relations International Media , Co Inc , Oslo Stock Exchange , Non Small Cell Lung Cancer , Chief Executive Officer , Experimental Cancer Medicine , College London , Principal Investigator , International Media , Abuse Regulation , Norwegian Securities Trading , Bergenbio , Nnounces , Positive , Data , Rom , Hase , Trial , Emcentinib , Combination , Pembrolizumab , Nsclc , Patients ,